Autoimmune Diseases  >>  decitabine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
decitabine / Generic mfg.
NCT01568333: A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia

Completed
2
45
RoW
Decitabine
Shandong University, Qingdao University, Shandong Provincial Hospital
Immune Thrombocytopenia
10/17
08/18

Download Options